Home News and Events Press Release
Press Release
Stay up to date on Argo Biopharma’s latest news and events.
Stay up to date on Argo Biopharma’s latest news and events.
Stay up to date on Argo Biopharma’s latest news and events.
Argo Biopharma has completed phase 1 clinical trials for BW-01, a siRNA candidate for cardiovascular diseases, in China and Australia.
Learn MoreShanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis.
Learn MoreArgo Biopharma closed series A+ financing of over 40 milion US dollars led by CS Capital.
Learn MoreArgo Biopharma’s first siRNA drug approved for clinical study in China, the United States, and Australia.
Learn MoreArgo Biopharma’s second siRNA drug approved for clinical study in Australia.
Learn MoreArgo Biopharma’s first siRNA drug approved for clinical study in Australia.
Learn MoreArgo Biopharma closed series A financing of 63 million US dollars.
Learn More
为了更好的呈现效果，移动端请竖屏浏览
